Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Andres Liivak
Morgan Lewis Adds Andres Liivak in Boston, Deepening Its Strong Life Sciences Transactions Capabilities
BOSTON, September 1, 2026: Morgan Lewis is strengthening its global life sciences transactional capabilities with the addition of Andres Liivak as a partner in the firm’s corporate and business transactions practice in Boston. He joins from an international law firm where he was global co-leader of the life sciences healthcare team.
New frontiers: How AI Is Transforming The Life Sciences Industry | JD Supra
January 22, 2026 Dr. Katrin Helle, Bethany Hills, Andres Liivak, Strati Sakellariou-Witt, Ajita Shukla White & Case LLP + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: The convergence of artificial intelligence (AI) and life sciences is no longer a distant promise. Companies operating in the sector are actively embracing the technology and are already achieving measurable results.
Big pharma firms return to the deal table in H1 | JD Supra
Cash-rich pharma firms look set for a buying spree, as favorable biotech valuations and patent expirations incentivize dealmaking Dealmaking activity in the US healthcare sector was robust in H1 2022 in the face of various macroeconomic headwinds. There were US$92.4 billion worth of deals announced in H1 2022. This was a 51 percent decrease from a record 2021, but it is still firmly ahead of pre-pandemic levels of activity.
Pharma and healthcare deliver strong results | JD Supra
Despite the absence of megadeals, M&A in the sector climbed from 2020 levels thanks in part to strong PE and SPAC activity Healthcare and pharmaceutical deals continued at a robust pace through 2021, registering the third-highest value of any sector, behind technology and industrials, and with values and volumes both increasing year-on-year. In 2021, deal value rose to US$288.9 billion, a 38 percent increase on 2020; the number of deals rose to 976, a 25 percent rise year-on-year.
Healthcare M&A on track to set new record in 2021 | JD Supra
Heightened interest in medical suppliers, contract research organizations and biotech firms resulted in an impressive year for healthcare dealmaking Dealmaking within the pharma, medical and biotech sector continued from its promising start to the year. Following robust activity throughout the year, Q1-Q3 deal value has already overtaken all annual totals on record except 2019, with three months of dealmaking left to record for the year.
House Bill Mandating User Data Portability and Platform Interoperability Could Impact Digital Companies of All Sizes | JD Supra
On June 24, 2021, H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act ("ACCESS Act"),1 was amended by the Committee on the Judiciary and ordered to be reported to the House of Representatives by a 25 to 19 vote.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Andres
Contact Andres, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack